Position available at CRCM: Group Leader in Onco-Hematology / Immuno-Oncology

Crcm Marseille; Marseille; Hybrid; EUR 90,000 - 130,000; Full time

Job summary

The Cancer Research Center of Marseille (CRCM) invites applications for a Group Leader to establish a new OHIO department team focusing on onco-hematology and/or immuno-oncology. The role emphasizes basic and translational research, integrating with IPC and CRCM.

The successful candidate will have a Ph.D. and/or M.D./Ph.D., a strong publication/funding record, and will develop an independent program leveraging multi-omics, imaging, flow cytometry, and computational biology, with access to

Qualifications

• Ph.D. and/or M.D./Ph.D. in hematology, oncology, immunology or related life sciences.
• Strong track record in cancer research with high‑impact publications.
• Ability to develop collaborative and translational projects.
• CV with publications, fundings and three referees; concise research summary (max 3 pages).
• Research proposal (max 3 pages) detailing vision and objectives.

Responsibilities

• Establish an innovative research program in onco‑hematology and/or immuno‑oncology.
• Lead a new OHIO group within the CRCM‑IPC ecosystem and foster translational collaborations.
• Leverage multi‑omics, imaging, flow cytometry, and computational biology with access to patient samples.

Skills

Scientific excellence

Innovation

Team leadership

Education

Ph.D. and/or M.D./Ph.D. in relevant fields

Job description

We are recruiting a Group Leader in Onco‑Hematology / Immuno‑Oncology

The Cancer Research Center of Marseille (CRCM) is inviting applications for a Group Leader position to establish a new research team within the Onco‑Hematology and Immuno‑Oncology Department ( OHIO) . This position is intended to enhance our capability for basic science and/or translational research capacity at the intersection of basic mechanisms, innovative therapies and clinical implementation in hematologic cancers and cancer immunology.

With over 450 collaborators spread across four departments, including the OHIO Department, the CRCM is an international research center affiliated with Inserm, CNRS, Aix‑Marseille University and the Paoli‑Calmettes Cancer Institute ( IPC ). The CRCM brings together interdisciplinary teams working on oncogenesis, tumor microenvironment, immune responses to cancer and biomarker discovery. It works closely with the IPC, a nonprofit general hospital with recognized expertise in the field of hematologic malignancies and early-phase clinical trials of cutting‑edge therapies.

The appointed Group Leader will establish an innovative research program in onco‑hematology and/or immuno‑oncology, emphasizing a robust fundamental/translational aspects and seamless integration within the CRCM–IPC ecosystem.

The successful candidate will receive a start‑up package and have a privileged access to cutting‑edge technological platforms for multi‑omics (including proteomics, single‑cell, genomics, and spatial‑omics), imaging and flow cytometry (including Immunomonitoring), drug screening and testing, and computational biology. The integrated CRCM–IPC environment offers direct access to patient samples and cohorts, and early‑phase trials at IPC, providing a unique framework for ambitious translational research.

The CRCM will provide engaged mentoring to the selected candidate to obtain a tenure position (CNRS or Inserm) and to secure extra funding (ATIPE/Avenir, INCa, ANR, ERC etc..). Researchers with permanent positions are also invited to apply.

Qualifications & Engagement

• Required qualifications: Ph.D. and/or M.D./Ph.D. in relevant fields (hematology, oncology, immunology or related life/medical sciences), with a strong track record in cancer research.
• Skills: Scientific excellence, innovation, team leadership, ability to develop collaborative and translational projects.
• Scientific engagement: High‑impact publications, proven ability to obtain competitive funding.
• A curriculum vitae (including a list of publications, fundings and contact info of three referee).
• A concise presentation of their current research and major achievements (max. 3 pages).
• A research proposal (max 3 pages) describing the scientific vision, medium‑term objectives, integration within the CRCM/IPC environment.